lactic acid has been researched along with Alveolitis, Fibrosing in 10 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pulmonary fibrosis is a chronic lung disease characterized by inflammation and collagen deposition, with an estimated mortality rate exceeding 70%." | 5.43 | Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. ( Choi, HG; Hwang, HS; Lee, C; Lee, EH; Lee, ES; Lee, S; Seo, J; Thao, LQ; Youn, YS, 2016) |
| "Although pulmonary dosing of large porous particles has been shown to sustain drug delivery for a few days, there are no reports on safety or long term delivery." | 5.39 | Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose. ( Dhanda, DS; Kompella, UB; Mirvish, SS; Tyagi, P, 2013) |
| "Pulmonary fibrosis is a chronic lung disease characterized by inflammation and collagen deposition, with an estimated mortality rate exceeding 70%." | 1.43 | Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. ( Choi, HG; Hwang, HS; Lee, C; Lee, EH; Lee, ES; Lee, S; Seo, J; Thao, LQ; Youn, YS, 2016) |
| "Pulmonary fibrosis is a common and dose-limiting side-effect of ionizing radiation used to treat cancers of the thoracic region." | 1.42 | Ionizing radiation induces myofibroblast differentiation via lactate dehydrogenase. ( Judge, JL; Kottmann, RM; Owens, KM; Phipps, RP; Pollock, SJ; Sime, PJ; Thatcher, TH; Williams, JP; Woeller, CF, 2015) |
| "Although pulmonary dosing of large porous particles has been shown to sustain drug delivery for a few days, there are no reports on safety or long term delivery." | 1.39 | Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose. ( Dhanda, DS; Kompella, UB; Mirvish, SS; Tyagi, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Q | 1 |
| Mei, S | 1 |
| Nie, F | 1 |
| Zhang, Z | 1 |
| Feng, J | 1 |
| Zhang, J | 1 |
| Qian, X | 1 |
| Gao, Y | 2 |
| He, Z | 1 |
| Xing, S | 1 |
| Dhanda, DS | 1 |
| Tyagi, P | 1 |
| Mirvish, SS | 1 |
| Kompella, UB | 1 |
| da Silva Bitencourt, C | 1 |
| Gelfuso, GM | 1 |
| Pereira, PA | 1 |
| de Assis, PA | 1 |
| Tefé-Silva, C | 1 |
| Ramos, SG | 1 |
| Arantes, EC | 1 |
| Faccioli, LH | 1 |
| Greguš, M | 1 |
| Foret, F | 1 |
| Kindlová, D | 1 |
| Pokojová, E | 1 |
| Plutinský, M | 1 |
| Doubková, M | 1 |
| Merta, Z | 1 |
| Binková, I | 1 |
| Skřičková, J | 1 |
| Kubáň, P | 1 |
| Judge, JL | 2 |
| Owens, KM | 2 |
| Pollock, SJ | 1 |
| Woeller, CF | 1 |
| Thatcher, TH | 2 |
| Williams, JP | 1 |
| Phipps, RP | 2 |
| Sime, PJ | 2 |
| Kottmann, RM | 2 |
| Trawick, E | 1 |
| Wahl, LA | 1 |
| Epa, AP | 1 |
| Lee, C | 1 |
| Seo, J | 1 |
| Hwang, HS | 1 |
| Thao, LQ | 1 |
| Lee, S | 1 |
| Lee, ES | 1 |
| Lee, EH | 1 |
| Choi, HG | 1 |
| Youn, YS | 1 |
| Zhang, H | 1 |
| Lv, W | 1 |
| Jiao, C | 1 |
| Duan, M | 1 |
| Liu, H | 1 |
| Han, B | 1 |
| Bye, PT | 1 |
| Anderson, SD | 1 |
| Woolcock, AJ | 1 |
| Young, IH | 1 |
| Alison, JA | 1 |
| Fireman, E | 1 |
| Shahar, I | 1 |
| Shoval, S | 1 |
| Messer, G | 1 |
| Dvash, S | 1 |
| Grief, J | 1 |
10 other studies available for lactic acid and Alveolitis, Fibrosing
| Article | Year |
|---|---|
The role of macrophage-fibroblast interaction in lipopolysaccharide-induced pulmonary fibrosis: an acceleration in lung fibroblast aerobic glycolysis.
Topics: Acceleration; Fibroblasts; Glycolysis; Humans; Lactic Acid; Lipopolysaccharides; Lung; Macrophages; | 2022 |
Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzo(a)pyrene; Bron | 2013 |
Hyaluronidase-loaded PLGA microparticles as a new strategy for the treatment of pulmonary fibrosis.
Topics: Animals; Cattle; Cell Count; Cell Line; Collagen; Cytoskeleton; Hyaluronoglucosaminidase; Lactic Aci | 2015 |
Monitoring the ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection.
Topics: Acetates; Adult; Aged; Ammonium Compounds; Asthma; Breath Tests; Butyrates; Calcium; Chlorides; Crow | 2015 |
Ionizing radiation induces myofibroblast differentiation via lactate dehydrogenase.
Topics: Animals; Cell Differentiation; Cells, Cultured; Enzyme Inhibitors; Gossypol; Humans; Isoenzymes; L-L | 2015 |
Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.
Topics: Animals; Cell Differentiation; Cell Line; Enzyme Inhibitors; Extracellular Matrix; Gene Knockdown Te | 2015 |
Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Topics: Administration, Inhalation; Aerosols; Animals; Bleomycin; Chitosan; Collagen; Hydroxyproline; Imagin | 2016 |
Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Chemistry, Pharmaceutical; Chromatography, Liquid; | 2011 |
Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen.
Topics: Air; Exercise Test; Female; Humans; Lactates; Lactic Acid; Lung Volume Measurements; Male; Middle Ag | 1982 |
Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Calcium; Cell Count; Cells, Cultured; Collagen; Creatine | 2001 |